PL03.13 Osimertinib With/Without Platinum-Based Chemotherapy as First-line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA2)
Pasi A. Jänne(Dana-Farber Cancer Institute), D. Planchard(Institut Gustave Roussy), Ying Cheng(Jilin Province Tumor Hospital), James Chih‐Hsin Yang(National Taiwan University Hospital), Noriko Yanagitani(The Cancer Institute Hospital), S.-W. Kim(Asan Medical Center), S. Sugawara(Sendai Kousei Hospital), Yanke Yu(Harbin Medical University), Yun Fan(Zhejiang Cancer Hospital), S.L. Geater(Prince of Songkla University), К. К. Лактионов(Ministry of Health), Chee Khoon Lee(St George Hospital), Natalia Valdivieso(Instituto Nacional de Enfermedades Neoplásicas), S. Ahmed(University Hospitals of Leicester NHS Trust), J.-M. Maurel(University of Cape Town), Igor Andrašina(Národný Onkologický Ústav), J.W. Goldman(Prostate Cancer Foundation), Dana Ghiorghiu(AstraZeneca (United Kingdom)), D. Kulkarni(AstraZeneca (United Kingdom)), X. Huang(AstraZeneca (United Kingdom)), K. Kobayashi(Saitama International Medical Center)
Cited by 10Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis